Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Sunday, September 28

2:30 PM - 2:37 PM PT

121 - Impact of MMR Status vs. Clinicopathologic Risk Factors on Locoregional Recurrence in Stage I Endometrioid Endometrial Cancer Treated with Brachytherapy Alone
Speaker: Hathout, Lara, MD, FRCPC - Rutgers Cancer Institute , New Brunswick, NJ
2:30 PM - 2:40 PM PT

127 - Mid-Treatment ctDNA to Predict Outcomes in Stage IIB-IIIC NSCLC Treated with MRI-Adapted Chemoradiation
Speaker: Hashmi, Ayesha, MD - Mayo Clinic Alix School of Medicine, Rochester, MN
2:30 PM - 2:40 PM PT

134 - Interrogating Contributions of the Sensory Neuroimmune Axis to Treatment Resistance in Head and Neck Squamous Cell Carcinoma
Speaker: Idlett-Ali, Shaquia, MD, PhD, BS - University of Colorado School of Medicine, Aurora, CO
2:30 PM - 3:45 PM PT

Discussant
Speaker: Klopp, Ann, MD, PhD - MD Anderson Cancer Center, Houston, TX
2:37 PM - 2:44 PM PT

122 - Radiation-Induced CTD-2292M14.1 Enhances Cervical Cancer Radioresistance by Promoting P62 Ubiquitination
Speaker: Zhou, Jie, PhD, RT - Sichuan Cancer Hospital and Institute, Chengdu, Sichuan
2:40 PM - 2:50 PM PT

101 - Phase II Prospective Trial of Image-Guided Cognitive-Sparing Brain Radiosurgery (COG-SRS) with a Connectivity Approach: The Future of Functional Preservation
Speaker: Puett, Andrew, MD, PhD - UC San Diego Radiation Medicine and Applied Sciences, La Jolla, CA
2:40 PM - 2:50 PM PT

108 - Evaluating Short Course Radiation and ctDNA for Organ Preservation: The Nonoperative Management and Early Response Assessment in Rectal Cancer (NOM-ERA) Trial
Speaker: Kim, Hyun, MD - Washington University School of Medicine, St. Louis, Missouri
2:40 PM - 2:50 PM PT

115 - Stereotactic Radiotherapy in 3 Fractions for Localized Prostate Cancer
Speaker: Sanguineti, Giuseppe, MD, Mr - Regina Elena National Cancer Institute, Rome, Lazio
2:40 PM - 2:50 PM PT

128 - Fatal Pulmonary Hemorrhage in Patients Treated with Hypofractionated RT for Stage II-III NSCLC
Speaker: Cooke, Saskia, MD - Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL), Amsterdam, Noord-Holl
2:40 PM - 2:50 PM PT

135 - IL-17-Producing Gd T Cells Recruited By Cgas-Sting-Dependent CCL20 in Macrophages Drive Radioresistance
Speaker: Kong, Lingyi, MD - Union Hospital Cancer Center, Tongji Medical College, HUST, Wuhan, Hubei
2:44 PM - 2:51 PM PT

123 - Transcriptomic Profiling Reveals Predictive Markers of Response to Concurrent Chemoradiotherapy plus Immune Checkpoint Inhibition in Cervical Cancer
Speaker: Cao, Yuan Jie, MD, PhD - Tianjin Medical University Cancer Institute and Hospital, Tian Jin, Tian Jin
2:50 PM - 3:00 PM PT

102 - Effect of Early Integrated Neuropsychological Care in Patients with Brain Metastases: A Phase 2 Randomized Controlled Trial (ATHENA Trial)
Speaker: Perlow, Haley, MD - Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH